You are here

  • Home
  • Archive
  • Volume 87, Issue 9
  • When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

Article info

Article menu
Download PDFPDF
PostScript
Letter
When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

Authors

  • Z A Ioannides Centre for Clinical Research, The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • R D Henderson Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • T Robertson Anatomical Pathology, Queensland Pathology, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • M Davis Department of Diagnostic Genomics, PathWest Laboratory Medicine WA, QEII Medical Centre, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • P A McCombe Centre for Clinical Research, The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr P A McCombe, Centre for Clinical Research, The University of Queensland Centre for Clinical Research, Brisbane, Queensland 4000, Australia; pamela.mccombe{at}uq.edu.au
View Full Text

Citation

Ioannides ZA, Henderson RD, Robertson T, et al
When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:1031-1032.

Publication history

  • Received July 14, 2015
  • Revised August 14, 2015
  • Accepted August 19, 2015
  • First published September 4, 2015.
Online issue publication 
August 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/